Methylenedioxymethoxyethylamphetamine

Chemical compound

Methylenedioxymethoxyethylamphetamine
[[File: Chemical structure of Methylenedioxymethoxyethylamphetamine |frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Methylenedioxymethoxyethylamphetamine (MDMEOET) is a psychedelic and entactogen of the substituted amphetamine class. It is structurally related to MDMA and other compounds in the methylenedioxyphenethylamine family.

Chemical structure and properties

MDMEOET is a derivative of amphetamine and is chemically similar to MDMA (3,4-methylenedioxy-N-methylamphetamine). The compound features a methylenedioxy ring attached to the phenyl group and an additional methoxyethyl group attached to the nitrogen atom of the ethylamine chain. This structural modification is thought to influence its pharmacological properties.

Pharmacology

MDMEOET is believed to act as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), similar to other entactogens. This means it likely increases the levels of these neurotransmitters in the brain, leading to its psychoactive effects. However, detailed studies on its pharmacokinetics and pharmacodynamics are limited.

Effects

The effects of MDMEOET are not well-documented, but it is presumed to produce effects similar to those of other entactogens, such as MDMA. These may include feelings of euphoria, increased empathy, and altered sensory perception. The duration and intensity of these effects can vary based on dosage and individual differences.

Legal status

The legal status of MDMEOET varies by country. In many jurisdictions, it may be considered a controlled substance due to its structural similarity to MDMA and other regulated amphetamines. Users should be aware of the legal implications of possessing or distributing this compound.

Synthesis

The synthesis of MDMEOET involves the reaction of 3,4-methylenedioxyphenyl-2-propanone (MDP2P) with an appropriate amine, followed by the introduction of the methoxyethyl group. This process requires advanced knowledge of organic chemistry and access to specific reagents and equipment.

Potential risks and safety

As with many research chemicals, the safety profile of MDMEOET is not well-established. Potential risks may include neurotoxicity, cardiovascular effects, and psychological disturbances. Users should exercise caution and consider the lack of comprehensive safety data.

Related pages

• MDMA
• Substituted amphetamines
• Psychedelic drug
• Entactogen